Please try another search
Index | Last | High | Low | Chg. | Chg. % | Time | ||
---|---|---|---|---|---|---|---|---|
Hang Seng M 100 | 4,685.41 | 4,698.21 | 4,602.95 | +62.37 | +1.35% | 00:05:02 | ||
Hang Seng Comp I | 2,474.32 | 2,479.03 | 2,435.54 | +31.16 | +1.28% | 00:05:02 | ||
Hang Seng CMC | 3,351.39 | 3,358.43 | 3,308.41 | +36.37 | +1.10% | 00:05:02 | ||
MSCI EM | 1,021.12 | 1,021.70 | 1,012.93 | +8.66 | +0.86% | 00:46:00 | ||
HS Healthcare | 2,113.00 | 2,114.32 | 2,073.50 | +12.43 | +0.59% | 00:05:02 | ||
Hang Seng Healthcare | 6,770.74 | 6,774.98 | 6,644.22 | +38.47 | +0.57% | 00:05:02 | ||
HS Hong Kong-Listed Biotech | 744.42 | 744.90 | 730.13 | +3.45 | +0.47% | 00:05:02 | ||
HS Composite LargeCap & MidCap | 2,598.46 | 2,603.47 | 2,556.84 | +33.55 | +1.31% | 00:05:02 | ||
HS Stock Connect Hong Kong | 2,471.77 | 2,475.73 | 2,431.75 | +33.93 | +1.39% | 00:05:02 | ||
HS Innovative Drug | 1,407.75 | 1,409.74 | 1,383.32 | +0.10 | +0.01% | 00:05:00 | ||
HS Composite MidCap & SmallCap | 2,016.83 | 2,020.88 | 1,993.29 | +19.29 | +0.97% | 00:05:02 | ||
HS SCHK Healthcare | 1,628.81 | 1,629.98 | 1,595.96 | +10.01 | +0.62% | 00:05:00 | ||
HS Large-Mid Cap | 2,171.60 | 2,175.95 | 2,136.54 | +28.18 | +1.31% | 00:05:02 | ||
HS Stock Connect Biotech 50 | 3,151.01 | 3,156.93 | 3,101.77 | +12.03 | +0.38% | 00:31:20 | ||
HS SCHK ML CN Companies | 2,461.22 | 2,466.27 | 2,418.32 | +34.52 | +1.42% | 00:05:02 | ||
HS SCHK Innovative Drug Select | 1,126.28 | 1,127.32 | 1,105.03 | +3.17 | +0.28% | 00:05:02 | ||
HS SCHK Innovative Drug | 1,599.23 | 1,601.00 | 1,570.63 | +2.77 | +0.17% | 00:05:00 | ||
HS Large-Mid Cap Value Comprehensive | 2,292.92 | 2,297.47 | 2,256.39 | +29.44 | +1.30% | 00:05:02 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review